The downward pressure, either brought about by shareholders anticipating a sell off by financing issues or financing issues putting short term pressure, both which should subside.

The embedded system offers a market where EDIG has some expertise, credibility and success, IFE.  It is not unlike a biotech having a new drug in the pipeline and offers more growth from the IFE market.  It is a good thing to have the company looking to expand revenue generation through innovation.

As for DM, we know there are billion dollar infringers waiting to be named.  I would not be surprised to have the timing coincide with the scheduling of an annual meeting and more new eVU business.

From .12 any or all of the above should have positive effects on the pps, seeing how the pps dropped on mostly good news.